Skip to content
MedicophiliaMedicophilia home

Topic Note

Heart Failure with Reduced Ejection Fraction: MCCQE Notes

Four drug classes change mortality and everything else treats symptoms. Knowing which is which answers most questions.

MCCQECardiology5 min read

Establishing the diagnosis

Symptoms and signs are unreliable on their own. Two tests carry the weight:

  • BNP or NT-proBNP — most useful for its negative predictive value. A normal level in an untreated breathless patient makes heart failure unlikely. Raised in AF, renal failure, PE, sepsis and age; lowered by obesity
  • Echocardiography — establishes the ejection fraction, and therefore which of the two diseases you are treating

Split on ejection fraction: HFrEF at ≤ 40% has disease-modifying therapy; HFpEF at ≥ 50% does not, beyond diuretics, comorbidity control and SGLT2 inhibitors.

The four pillars of HFrEF

All four reduce mortality. Start them all, at low dose, and titrate — the modern approach is early combination rather than sequential maximisation of one class:

  1. ARNI (sacubitril–valsartan) in preference to an ACE inhibitor, or an ACE inhibitor/ARB if ARNI is not available. Requires a 36-hour washout from an ACE inhibitor to avoid angioedema
  2. Beta-blocker — only bisoprolol, carvedilol or metoprolol succinate have the evidence. Start when euvolaemic, never during decompensation
  3. Mineralocorticoid receptor antagonist — spironolactone or eplerenone; monitor potassium and creatinine
  4. SGLT2 inhibitor — dapagliflozin or empagliflozin, with or without diabetes

Loop diuretics relieve congestion and do not change mortality. Titrate to symptoms and weight.

Drugs to stop or avoid

  • NSAIDs — sodium retention and renal impairment
  • Non-dihydropyridine calcium channel blockers (verapamil, diltiazem) — negatively inotropic
  • Thiazolidinediones — fluid retention
  • Most antiarrhythmics other than amiodarone

Devices

  • ICD for ejection fraction ≤ 35% despite ≥ 3 months of optimal therapy, with a reasonable life expectancy
  • CRT additionally for QRS ≥ 150 ms, especially with LBBB morphology

Acute decompensation

The picture divides usefully into wet/dry and warm/cold:

  • Wet and warm (most common): IV loop diuretic, nitrates if hypertensive, non-invasive ventilation for pulmonary oedema
  • Wet and cold: low output — inotropes, and consider mechanical support
  • Look for the trigger every time: ischaemia, arrhythmia (especially new AF), infection, non-adherence, NSAIDs, anaemia, thyroid disease, pulmonary embolism

What to check when it is not improving

New heart failure needs a cause: ischaemic disease (the commonest), valvular disease, hypertension, alcohol, thyroid, iron overload, amyloid, peripartum, chemotherapy (anthracyclines, trastuzumab), tachycardia-induced. Iron deficiency — ferritin < 100, or < 300 with saturation < 20% — is worth correcting intravenously; it improves symptoms independent of anaemia.

heart failurecardiologymccqe

Related reading